Investigation of the


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 Aug 2022
Historique:
received: 02 07 2022
revised: 29 07 2022
accepted: 04 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

The emergence of the SARS-CoV-2 coronavirus pandemic in China in late 2019 led to the fast development of efficient therapeutics. Of the major structural proteins encoded by the SARS-CoV-2 genome, the SPIKE (S) protein has attracted considerable research interest because of the central role it plays in virus entry into host cells. Therefore, to date, most immunization strategies aim at inducing neutralizing antibodies against the surface viral S protein. The SARS-CoV-2 S protein is heavily glycosylated with 22 predicted

Identifiants

pubmed: 36014368
pii: molecules27165119
doi: 10.3390/molecules27165119
pmc: PMC9412417
pii:
doi:

Substances chimiques

Polysaccharides 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union's Horizon 2020 Research and Innovation Programme
ID : 774078 Pharma Factory project

Références

Plant Biotechnol J. 2019 Feb;17(2):505-516
pubmed: 30058762
Vaccines (Basel). 2021 Nov 17;9(11):
pubmed: 34835268
Plant Biotechnol J. 2022 Jul;20(7):1363-1372
pubmed: 35325498
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Plant Biotechnol J. 2008 May;6(4):392-402
pubmed: 18346095
Elife. 2020 Oct 26;9:
pubmed: 33103998
Anal Chem. 2021 Feb 2;93(4):2003-2009
pubmed: 33406838
Mol Cell Proteomics. 2021;20:100058
pubmed: 33077685
Plant Biotechnol J. 2015 Jun;13(5):717-25
pubmed: 25523794
Front Bioeng Biotechnol. 2022 Feb 18;10:838365
pubmed: 35252146
Nat Med. 2021 Jun;27(6):1071-1078
pubmed: 34007070
Front Chem. 2022 Feb 01;9:816544
pubmed: 35178379
Biochem Biophys Res Commun. 2016 Oct 14;479(2):266-271
pubmed: 27638310
Cell Mol Immunol. 2022 Feb;19(2):222-233
pubmed: 34983950
Glycobiology. 2019 Aug 20;29(9):620-624
pubmed: 31184695
Eur J Biochem. 1991 Aug 1;199(3):647-52
pubmed: 1868849
Plant Biotechnol J. 2007 Sep;5(5):657-63
pubmed: 17678502
J Med Virol. 2022 Oct;94(10):4628-4643
pubmed: 35705439
Glycobiology. 1999 Apr;9(4):365-72
pubmed: 10089210
Front Plant Sci. 2016 Jun 15;7:814
pubmed: 27379116
Biomedicines. 2022 Jul 22;10(8):
pubmed: 35892674
Plant Physiol. 1999 Oct;121(2):333-44
pubmed: 10517824
Plant Mol Biol. 1998 Sep;38(1-2):31-48
pubmed: 9738959
Sci Rep. 2021 Dec 7;11(1):23561
pubmed: 34876606
Glycobiology. 2020 Dec 9;30(12):981-988
pubmed: 32363391
Viruses. 2021 Aug 12;13(8):
pubmed: 34452461
Sci Rep. 2020 Oct 19;10(1):17698
pubmed: 33077899
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Front Plant Sci. 2021 Jun 15;12:689104
pubmed: 34211491
Front Plant Sci. 2020 Dec 23;11:612781
pubmed: 33424908
Plant Biotechnol J. 2011 Dec;9(9):1120-30
pubmed: 21819534
J Proteome Res. 2017 Jul 7;16(7):2560-2570
pubmed: 28516782

Auteurs

Juliette Balieu (J)

Université de Rouen Normandie, Laboratoire GlycoMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, 76000 Rouen, France.

Jae-Wan Jung (JW)

Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK.
Department of Molecular Biology, Jeonbuk National University, Jeonju 54896, Korea.

Philippe Chan (P)

Université de Rouen Normandie, INSERM US 51, CNRS UAR 2026, HeRacLeS, 76000 Rouen, France.

George P Lomonossoff (GP)

Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK.

Patrice Lerouge (P)

Université de Rouen Normandie, Laboratoire GlycoMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, 76000 Rouen, France.

Muriel Bardor (M)

Université de Rouen Normandie, Laboratoire GlycoMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, 76000 Rouen, France.
Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, UMR CNRS 8576, 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH